ORAMED PHARMACEUTICALS INC. (37) | Business Finance (10)

Browse by Subcategory

Recent Contracts

Form of Securities Purchase Agreement, dated as of November 3, 2021 between the Company and each Purchaser in the Offering (Filed With SEC on November 4, 2021)
Equity Distribution Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on September 1, 2021)
Underwriting Agreement, dated February 27, 2020, between Oramed Pharmaceuticals Inc. and National Securities Corporation (Filed With SEC on February 28, 2020)
Form of Underwriters Warrant (Filed With SEC on February 28, 2020)
Form of Notice of Stock Option Award and Stock Option Award Agreement (Filed With SEC on November 27, 2019)
Equity Distribution Agreement, dated July 15, 2021, by and between the Company and Canaccord Genuity (Filed With SEC on July 15, 2021)
Equity Distribution Agreement, dated June 16, 2021, by and between the Company and Canaccord Genuity (Filed With SEC on June 16, 2021)
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity (Filed With SEC on December 1, 2020)
Amendment to the Equity Distribution Agreement, dated February 10, 2020, between Canaccord Genuity LLC and Oramed Pharmaceuticals Inc (Filed With SEC on April 6, 2020)
Equity Distribution Agreement, dated September 5, 2019, by and between the Company and Canaccord Genuity (Filed With SEC on September 5, 2019)